NFKB1 and B-cell chronic lymphocytic leukemia: Hence, SMDY2 could maintain mature B cells survival through the non‐canonical NF‐κB pathway and which could also explain why B cells are excessive activation in some autoimmune diseases and chronic lymphocytic leukemia accompanied by the high expression of SMYD2.